A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity

Journal of Vascular Surgery

Volumn 37, Issue 5, 2003, Pages 1059-1066

  Ailawadi, Gorav ^a   Knipp, Brian S ^a   Lu, Guanyi ^a   Roelofs, Karen J ^a   Ford, John W ^a   Hannawa, Kevin K ^a   Bishop, Keith ^a   Thanaporn, Porama ^a   Henke, Peter K ^a   Stanley, James C ^a   Upchurch Jr , Gilbert R ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART TRANSPLANTATION; ISOGRAFT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA; ZYMOGRAPHY;

EID: 0038372433     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2003.163     Document Type: Article

References (37)

1. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997;95:205-12.
2. Wojowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drugs 1997;15:61-75.
3. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145-51.
4. Patel MI, Melrose J, Ghosh P, Appelberg M. Increased synthesis of matrix metalloproteinase by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 1996;24:82-92.
5. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci 1996;800:157-74.
6. Davis V, Persidskaia R, Baca-Regen L, Itoh Y, Nagase H, Persidsky Y, et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 1998;18:1625-33.
7. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-9.
8. Tamarina NA, Mcillan WD, Shively VP, Pearce WH. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997;122:264-71.
9. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase12) in abdominal aortic aneurysms. J Clin Invest 1998;102:1900-10.
10. Allaire E, Forough R, Clowes M, Starcher B, Clowes AW. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 1998;102:1413-20.
11. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A. Stromelysin-1 (matrix metaolloproteinase-3) and tissue inhibitor of metallo mctatioproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002;105:477-82.
12. Treharne GD, Boyle JR, Goodall S, Loftus IM, Bell PR, Thompson MM. Marimastat inhibits clastin degradation and matrix metalloproteinase-2 activity in a model of aneurysm disease. Br J Surg 86;1999:1053-8.
13. Dobrin PB. Elastin, collagen, and some mechanical aspects of arterial aneurysms. J Vasc Surg 1989;9:396-8.
14. Bigatel DA, Elmore JR, Carey DJ, Cizmeci-Smith G, Franklin DP, Youkey JR. The matrix metalloproteinasc inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg 1999;29:130-9.
15. Moore G, Liao S, Curci JA, Starcher BC, Martin RL, Hendricks RT, et al. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). J Vasc Surg 1999;29:522-32.
16. Pentrince D, Liao S, Holmes Dr, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 1996;23:336-46.
17. Halloran BG, Davis VA, McManus BM, Lynch TG, Baxter BT. Localization of aortic disease is associated with intrinsic differences in aortic structure. J Surg Res 1995;59:17.
18. Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals: Deviation of man from the usual pattern. Circ Res 1969;25:677-86.
19. Wolinsky H. Comparison of medial growth of human thoracic and abdominal aortas. Circ Res 1970;27:531-8.
20. Zatina MA, Zarins CK, Gewertz BL, Glagov S. Role of medial lamellar architecture in the pathogenesis of aortic aneurysms. J Vasc Surg 1984;1:442-8.
21. Moore JE Jr, Ku DN, Zarins CK, Glagov S. Pulsatile flow visualization in the abdominal aorta under differing conditions: Implications for increased susceptibility to atherosclerosis. J Biomech Engin 1992;114:391-7.
22. Pederson EM, Sung HW, Yoganathan AP. Influence of abdominal aortic curvature and resting versus exercise conditions on velocity fields in the normal abdominal aortic bifurcation. J Biomech Engin 1994;116:347-54.
23. Wassef M, Baxter BT, Chisholm RL, Dalman KL, Fillinger MF, Heinecke J, et al. Pathogenesis of abdominal aortic aneurysms: A multidisciplinary research program supported by the National Heart, Lung and Blood Institute. J Vasc Surg 2001;34:730-8.
24. Horton WE Jr, Udo I, Precht P, Balakir R, Hasty, K. Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation. In Vitro Cell Dev Biol 1998;34:378-84.
25. Overall CM. Regulation of tissue inhibitor of matrix metalloproteinase expression. Ann NY Acad Sci 1994;732:51-64.
26. Davis VA, Persidskaia RN, Baca-Regen LM, Fiotti N, Halloran BG, Baxter BT. Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res 2001;101:152-6.
27. Reis ED, Li J, Fayad ZA, Rong JX, Hansoty D, Aguinaldo JG, et al. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg 2001;34:541-7.
28. Upchurch GR Jr, Ford JW, Weiss SJ, Knipp BS, Peterson DA, Thompson RW, et al. Nitric oxide inhibition increases MMP-9 expression by rat aortic smooth muscle cells in vitro. J Vasc Surg 2001;34:76-83.
29. Eagleton MJ, Peterson D, Sullivan V, Roelofs K, Ford J, Stanley JC, et al. Nitric oxide inhibition increases aortic matrix metalloproteinase-9 expression. J Surg Res 2002;104:15-21.
30. Oliver GW, Stetler-Stevenson WG, Kleiner DE. Quantitative reverse zymography: Analysis ofpicogram amounts of metalloproteinase inhibitor using gelatinase A and B reverse zymograms. Anal Biochem 1997;244:161-6.
31. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998;29:2189-95.
32. Woessner JF, Nagase H. Matrix metalloproteinases and TIMPs: Introduction to the tissue inhibitors of metalloproteinases (TIMPs). New York: Oxford University Press; 2000. p 8-9.
33. Peterson DA, Granziano KV, Ford JW, Deogracias MP, Knipp BS, Eagleton MJ, et al. Nitric oxide synthase inhibition in vitro is associated with increased nuclear factor-KB activity in rat aortic smooth muscle cells. Surg Forum 2001;52:370-2.
34. McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999;29:122-7.
35. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: An elastolytic metalloproteinase expressed by aneurysm infiltrating macrophages. J Clin Invest 1995;96:318-26.
36. McMillan WD, Patterson BK, Keen RR, Pearce WH. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg 1995;22:295-305.
37. Chesler NC, Ku DN, Galls ZS. Transmural pressure induces matrixdegrading activity in porcine arteries ex vivo. Am J Physiol 1999;277: H2002-9.